CMS Coverage And Nationwide Partnerships Will Expand Exoskeleton Adoption

AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Published
01 May 25
Updated
01 Aug 25
AnalystConsensusTarget's Fair Value
US$34.75
90.0% undervalued intrinsic discount
01 Aug
US$3.49
Loading
1Y
-76.3%
7D
-23.0%

Author's Valuation

US$34.7

90.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 Aug 25
Fair value Decreased 7.33%

Despite sharply improved consensus revenue growth forecasts, a significant rise in the company's future P/E multiple has driven analysts to lower Ekso Bionics Holdings' fair value estimate from $37.50 to $34.75. What's in the News Launched eksoUniversity, an online continuing education platform for physical therapists, offering courses approved for CEUs in over 30 states.